NATACYN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Natacyn, and when can generic versions of Natacyn launch?
Natacyn is a drug marketed by Harrow Eye and is included in one NDA.
The generic ingredient in NATACYN is natamycin. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the natamycin profile page.
Summary for NATACYN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 35 |
Patent Applications: | 4,255 |
Drug Prices: | Drug price information for NATACYN |
What excipients (inactive ingredients) are in NATACYN? | NATACYN excipients list |
DailyMed Link: | NATACYN at DailyMed |
Pharmacology for NATACYN
Drug Class | Polyene Antimicrobial |
Anatomical Therapeutic Chemical (ATC) Classes for NATACYN
US Patents and Regulatory Information for NATACYN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Harrow Eye | NATACYN | natamycin | SUSPENSION;OPHTHALMIC | 050514-001 | Approved Prior to Jan 1, 1982 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |